|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense, net | |||||
| Other income (expense), net | |||||
| Net loss and comprehensive loss | |||||
| Accretion of preferred stock dividends | |||||
| Deemed dividend arising from beneficial conversion feature of convertible preferred stock | |||||
| Net loss applicable to common stockholders | |||||
| Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | |||||
| Weighted average common shares used to compute net loss per share, basic and diluted (in shares) |
Loading...
